SCIE期刊Therapeutic Advances in Psychopharmacology 2024/2025影响因子:3.487 (THER ADV PSYCHOPHARM) (2045-1253). (PHARMACOLOGY

显示全部楼层 · 发表于 2025-3-25 12:00:17

Submitted on: 07 November 2006. Revised on: 21 November 2006. Accepted on: 13 December 2006. Therapeutic Advances in Psychopharmacology

显示全部楼层 · 发表于 2025-3-25 15:51:40

显示全部楼层 · 发表于 2025-3-25 22:04:05

显示全部楼层 · 发表于 2025-3-26 02:19:51

Submitted on: 13 May 2007. Revised on: 07 June 2007. Accepted on: 02 July 2007. Therapeutic Advances in Psychopharmacology

显示全部楼层 · 发表于 2025-3-26 04:20:22

Submitted on: 08 July 2023. Revised on: 31 July 2023. Accepted on: 10 August 2023. Therapeutic Advances in Psychopharmacology

显示全部楼层 · 发表于 2025-3-26 11:30:29

Submitted on: 16 September 2004. Revised on: 26 October 2004. Accepted on: 04 November 2004. Therapeutic Advances in Psychopharmacology

显示全部楼层 · 发表于 2025-3-26 12:46:21

Submitted on: 24 August 2006. Revised on: 04 October 2006. Accepted on: 28 October 2006. Therapeutic Advances in Psychopharmacology

显示全部楼层 · 发表于 2025-3-26 17:30:19

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 02:45
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved